文献速递乳腺癌放疗放疗物理与技术

乳腺癌两阶段扩张器/假体再造患者中放疗方式(质子/光子)、时机与并发症发生率

Radiation Modality (Proton/Photon), Timing, and Complication Rates in Patients With Breast Cancer Receiving 2-Stages Expander/Implant Reconstruction.
PubMed 文献 · Pract Radiat Oncol · 2022-06-27

本研究回顾性分析了2000至2019年间在本机构接受即刻两阶段扩张器/假体再造的661例乳腺癌患者,比较无放疗、扩张器放疗(RTE)和假体放疗(RTI)的并发症发生率。结果显示RTE较RTI显著增加总体再造失败率(39.5% vs 31.5%;OR 2.11;P=0.02),质子治疗较光子加或不加胸壁补量显著增加包膜挛缩和总体再造失败。

要点

  • 扩张器放疗较假体放疗显著增加总体再造失败率(39.5% vs 31.5%;OR 2.11;P=0.02)。
  • 质子治疗较光子加胸壁补量组和光子不加胸壁补量组均显著增加包膜挛缩(OR 5.4;P=0.01 和 OR 10.9;P<0.001)。
  • RTE与RTI的5年局部控制率分别为95.3%和97.7%(HR 1.2;P=0.7),无显著差异。

核心结论

  • 交换至假体前的早期扩张器放疗显著增加总体再造失败率,且未改善局部控制。
  • 质子治疗显著增加包膜挛缩率和总体再造失败,导致更多翻修手术。

研究设计与样本

  • 回顾性病历复习,纳入2000至2019年在本机构接受即刻两阶段扩张器/假体再造(伴或不伴乳房切除术后放疗)的661例乳腺癌患者。
  • 患者分为3组:无放疗、扩张器放疗(RTE)、交换至假体后放疗(RTI)。
  • 放疗采用三维适形光子(伴或不伴胸壁补量)或质子治疗。

主要发现

  • 661例中309例(46.7%)接受乳房切除术后放疗,其中220/309(71.2%)接受RTE,89/309(28.8%)接受RTI;309例中17例(5.5%)接受质子治疗。
  • RTE组与RTI组并发症:感染/坏死22.7% vs 15.7%,包膜挛缩13.6% vs 19.1%,总体再造失败39.5% vs 31.5%。
  • 质子治疗患者中8/17(47%)发生包膜挛缩,胸壁补量组为16.4%(24/146),无胸壁补量组为10.3%(15/146)。
  • 多因素校正分析显示RTI与RTE在感染/坏死和包膜挛缩方面无显著差异;RTE较RTI显著增加总体再造失败(39.5% vs 31.5%;OR 2.11;P=0.02)。
  • 质子治疗较胸壁补量组和无胸壁补量组均显著增加包膜挛缩(OR 5.4;P=0.01 和 OR 10.9;P<0.001);质子治疗显著增加总体再造失败。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Our purpose is to explore the effect of postmastectomy radiation therapy (PMRT) modality and timing on complication rates in breast cancer patients receiving immediate 2-stages expander/implant. METHODS AND MATERIALS: We reviewed the charts of 661 patients who underwent immediate 2-stages expander/implant with/without PMRT at our institution from 2000 to 2019. Patients were divided into 3 cohorts: no radiation, PMRT to expanders (RTE), and PMRT to implants after expander exchange (RTI). PMRT was delivered either with 3-dimensional conformal photon with or without chest wall boost (CWB) or proton therapy. Reconstruction complications were defined as infection/necrosis requiring debridement, capsular-contracture requiring capsulotomy, and reconstruction failure requiring prothesis removal. Logistic regression and Cox models were used to assess the effect of different radiation therapy modalities on complication rates and local control. RESULTS: Among 661 patients, 309 (46.7%) received PMRT, 220 of the 309 (71.2%) received RTE before exchange, and 89 (28.8%) received RTI after exchange. Seventeen out of 309 (5.5%) patients received proton therapy. The complications among RTE versus RTI cohorts were 22.7% versus 15.7% for infection/necrosis, 13.6% versus 19.1% for capsular-contracture, and 39.5% versus 31.5% for overall reconstruction failure, respectively. Among proton patients, 8/17 (47%) developed capsular contracture compared with 16.4% (24/146) and 10.3% (15/146) in CWB and non-CWB groups, respectively. Adjusted multivariable analysis showed no significant difference between RTI and RTE in terms of infection/necrosis and capsular contracture. Yet, RTE significantly increased overall reconstruction failure compared with RTI (39.5% vs 31.5%; odds ratio [OR], 2.11; P = .02). Protons significantly increased capsular contracture compared with both CWB and non-CWB groups (OR, 5.4; P = .01 and OR, 10.9; P < .001, respectively). Moreover, proton significantly increased overall reconstruction failure. The 5-year local control rates were 95.3% and 97.7% for RTE and RTI, respectively (hazard ratio, 1.2; P = .7). CONCLUSIONS: Early radiation to the expander before the exchange to implant significantly increased overall reconstruction failure without improving local control. Protons significantly increased capsular contracture rates and overall reconstruction failure leading to more revision surgeries.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Naoum GE, Ioakeim MI, Shui AM, et al. Radiation Modality (Proton/Photon), Timing, and Complication Rates in Patients With Breast Cancer Receiving 2-Stages Expander/Implant Reconstruction. Pract Radiat Oncol. 2022. PMID: 35989216. doi:10.1016/j.prro.2022.05.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。